US Broker Ratings

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 20.82% Potential Upside in Medical Devices

Integer Holdings Corporation (NYSE: ITGR) operates at the nexus of the healthcare and medical devices industries, serving as a critical partner to multi-national original equipment manufacturers. With a market capitalization..

Amgen Inc. (AMGN) Stock Analysis: Impressive Dividend Yield Amidst Conservative Growth Outlook

For individual investors eyeing opportunities in the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling case. As a titan in the drug manufacturing industry, Amgen holds a formidable market..

Ascendis Pharma A/S (ASND) Stock Analysis: 21.62% Potential Upside with Strong Buy Ratings

Ascendis Pharma A/S (NASDAQ: ASND) is capturing the attention of investors with its impressive growth trajectory and robust analyst support, offering a potential upside of 21.62%. Operating in the dynamic..

Biogen Inc. (BIIB) Stock Analysis: Navigating Potential Upside Amid Sector Dynamics

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, continues to intrigue investors with its focus on neurological and neurodegenerative diseases. With a market capitalization of $25.72 billion, Biogen..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating Challenges in the Healthcare Sector

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, has been navigating a complex landscape marked by both opportunities and challenges. As a company that provides..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Potential Upside of Over 24% Amid Robust Revenue Growth

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on developing treatments for rare neuroendocrine diseases. With a current market capitalization of $6.79 billion, Rhythm..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: 20% Potential Upside Ignites Investor Interest

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a leading player in the biopharmaceutical sector specializing in therapies for central nervous system (CNS) disorders, has captured the attention of investors with its promising..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring Growth Potential with an 18 Buy Rating Consensus

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a titan in the biotechnology sector, continues to capture investor interest with its robust portfolio of innovative treatments and promising collaborations. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Healthcare Innovator with 18.82% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP), a trailblazer in the healthcare sector, is attracting attention from investors with its innovative solutions for obstructive sleep apnea (OSA). As the company continues..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility in Healthcare

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is making waves in the healthcare sector, particularly within the niche of Traditional Chinese Medicine (TCM) for neurocognitive disorders. As a company headquartered in..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Giant with 11.45% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a stalwart in the healthcare sector, is making waves with its impressive market presence and growth potential. With a market capitalization of $6.4 billion, RadNet stands..

Vaxcyte, Inc. (PCVX) Investor Outlook: A 92% Upside Potential in the Biotech Sector

Vaxcyte, Inc. (PCVX), a clinical-stage innovator in the biotechnology industry, is garnering attention for its ambitious vaccine pipeline and a striking potential upside of 92.55%. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 16.69% Potential Upside for Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) is steadily carving its niche in the dynamic healthcare sector, particularly within the health information services industry. With a robust market capitalization of $34.9..

Nuvalent, Inc. (NUVL) Stock Analysis: Promising 34% Upside Amid Robust Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, has been drawing significant attention in the biotechnology sector. With a market cap of $8.22 billion, Nuvalent is strategically positioned in the..

Elevance Health, Inc. (ELV): Investor Outlook with a 20% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors with its substantial market cap of $72.45 billion and a potential..

AstraZeneca PLC (AZN) Stock Analysis: A Healthcare Giant with Promising Growth and Strategic Collaborations

AstraZeneca PLC (NASDAQ: AZN), a leading player in the global healthcare sector, continues to capture the attention of investors with its robust market presence and strategic collaborations. Headquartered in Cambridge,..

Bio-Techne Corp (TECH) Investor Outlook: Analyzing a Potential 12.41% Upside in the Biotechnology Sector

Bio-Techne Corporation (NASDAQ: TECH), a leading player in the healthcare sector, operates within the biotechnology industry, developing and manufacturing a diverse array of life science reagents, instruments, and services. With..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring Growth Potential with a 9.15% Upside

United Therapeutics Corporation (UTHR), a key player in the healthcare sector and a prominent name in the specialty and generic drug manufacturing industry, has recently caught the attention of investors...

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Look at its 5.58% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $201.32 billion, the..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Challenging Landscape with Potential 18% Upside

Avantor, Inc. (NYSE: AVTR) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $7.85 billion, Avantor is..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds